# Palo Alto Institute

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/palo-alto-institute/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 56.2 |
| Citations | 775,685 |
| City | San Mateo |
| Country | US |
| Description | Palo Alto Institute is a research organisation in San Mateo, US. OpenAlex records 8,037 works and 775,685 citations for it. 1,724 researchers list it as their most recent affiliation. |
| Homepage | http://www.paloaltoinstitute.org/ |
| OpenAlex ID | https://openalex.org/I4210124598 |
| Region | California |
| Researchers | 1,724 |
| ROR ID | https://ror.org/02xf01n45 |
| Type | nonprofit |
| Works | 8,037 |

## University papers

Showing 12 of 19.

- [An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage](https://scholariq.org/papers/an-ultrasensitive-method-for-quantitating-circulating-tumor-dna-with-broad/)
- [Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry](https://scholariq.org/papers/immune-checkpoint-inhibitors-for-patients-with-advanced-lung-cancer-and/)
- [Integrated digital error suppression for improved detection of circulating tumor DNA](https://scholariq.org/papers/integrated-digital-error-suppression-for-improved-detection-of-circulating-tumor/)
- [Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling](https://scholariq.org/papers/early-detection-of-molecular-residual-disease-in-localized-lung-cancer-by/)
- [Integrating genomic features for non-invasive early lung cancer detection](https://scholariq.org/papers/integrating-genomic-features-for-non-invasive-early-lung-cancer-detection/)
- [Rociletinib in <i>EGFR</i>-Mutated Non–Small-Cell Lung Cancer](https://scholariq.org/papers/rociletinib-in-i-egfr-i-mutated-non-small-cell-lung-cancer/)
- [Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients](https://scholariq.org/papers/circulating-tumour-dna-profiling-reveals-heterogeneity-of-egfr-inhibitor/)
- [Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke](https://scholariq.org/papers/lipids-lipoproteins-and-metabolites-and-risk-of-myocardial-infarction-and-stroke/)
- [<i>EGFR</i> -Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes](https://scholariq.org/papers/i-egfr-i-mutant-adenocarcinomas-that-transform-to-small-cell-lung-cancer-and/)
- [Sequence modeling and design from molecular to genome scale with Evo](https://scholariq.org/papers/sequence-modeling-and-design-from-molecular-to-genome-scale-with-evo-2/)
- [Heterogeneity Underlies the Emergence of <i>EGFR</i> T790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor](https://scholariq.org/papers/heterogeneity-underlies-the-emergence-of-i-egfr-i-t790-wild-type-clones/)
- [Targeting RET in Patients With <i>RET</i>-Rearranged Lung Cancers: Results From the Global, Multicenter <i>RET</i> Registry](https://scholariq.org/papers/targeting-ret-in-patients-with-i-ret-i-rearranged-lung-cancers-results-from-the/)

## University top topics

Showing 8 of 25.

- [Toxoplasma gondii Research Studies](https://scholariq.org/topics/toxoplasma-gondii-research-studies/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Child Nutrition and Water Access](https://scholariq.org/topics/child-nutrition-and-water-access/)
- [Herpesvirus Infections and Treatments](https://scholariq.org/topics/herpesvirus-infections-and-treatments/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Cytomegalovirus and herpesvirus research](https://scholariq.org/topics/cytomegalovirus-and-herpesvirus-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.